| Bioactivity | Radezolid (RX-1741) is a oxazolidinone antibiotic. Radezolid is active against Staphylococcus, Chlamydia, and Legionella species, and remains active against Linezolid-resistant strains[1][2]. | ||||||||||||
| Invitro | Radezolid MICs are systematically equal to or lower (up to 3 log2 dilutions) than those of linezolid for all linezolid-susceptible strains, with an 8-fold difference for the linezolid-resistant strains. Radezolid shows a greater potency than linezolid, independent of the bacteria tested, when concentrations are expressed on a weight (mg/L) basis. Radezolid shows an improved potency compared to that of linezolid when concentrations are expressed on a weight (mg/L) basis[1]. Radezolid and TR-700 perform well against 3-copy G2447T, G2576T, and G2576T/T2571C mutants[2]. | ||||||||||||
| Name | Radezolid | ||||||||||||
| CAS | 869884-78-6 | ||||||||||||
| Formula | C22H23FN6O3 | ||||||||||||
| Molar Mass | 438.45 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Radezolid
CAS: 869884-78-6 F: C22H23FN6O3 W: 438.45
Radezolid (RX-1741) is a oxazolidinone antibiotic. Radezolid is active against Staphylococcus, Chlamydia, and Legionella
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.